YOUSIF CAPITAL MANAGEMENT, LLC

Position in ALKS — Alkermes plc.

CIK 1858789 BLOOMFIELD HILLS, MI

Back to ALKS Full portfolio

Position in ALKS

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$2,394,399

+$780,039 QoQ

Shares Held

45,699

+0.1% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#162

of 421 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 26% Shared 0% None 74%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

YOUSIF CAPITAL MANAGEMENT, LLC holds $35,190,450 across 18 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	12,446	$6,743,616
2	NBIX	Neurocrine Biosciences Inc	28,979	$4,884,120
3	ZTS	Zoetis Inc.	53,813	$3,867,002
4	ELAN	Elanco Animal Health Inc	146,732	$3,611,074
5	ALKS	Alkermes plc. This page	45,699	$2,394,399
6	HIMS	Hims & Hers Health, Inc.	59,798	$2,073,196
7	LNTH	Lantheus Holdings, Inc.	18,586	$2,061,930
8	VTRS	Viatris Inc	110,271	$1,751,103

All Filings in ALKS

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,394,399	45,699	+0.1%	Shares	Sole	2026-07-16
2026-03-31	$1,614,360	45,655	-0.8%	Shares	Sole	2026-04-24
2025-12-31	$1,287,387	46,011	-12.6%	Shares	Sole	2026-01-21
2025-09-30	$1,579,890	52,663	-16.3%	Shares	Sole	2025-10-14
2025-06-30	$1,801,028	62,951	+2.6%	Shares	Sole	2025-07-25
2025-03-31	$2,025,677	61,347	-2.1%	Shares	Sole	2025-04-14
2024-12-31	$1,801,555	62,641	-3.7%	Shares	Sole	2025-01-27
2024-09-30	$1,820,217	65,031	-5.4%	Shares	Sole	2024-10-30
2024-06-30	$1,657,525	68,777	-9.6%	Shares	Sole	2024-07-31
2024-03-31	$2,059,837	76,093	-8.8%	Shares	Sole	2024-04-26
2023-12-31	$2,313,432	83,397	—	Shares	Sole	2024-02-01
No filing history on record for this holder in this stock.